Verve Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Aug '25 Aug 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	6	6	3	7	6	15	Upgrade
Market Cap Growth	78.33%	78.33%	-53.46%	25.81%	-60.26%	2.63%	Upgrade
Enterprise Value	18	17	14	17	15	23	Upgrade
Last Close Price	0.01	0.01	0.01	0.02	0.02	0.04	Upgrade
PS Ratio	3.02	3.02	1.52	3.25	2.27	5.85	Upgrade
PB Ratio	-0.37	-0.37	-0.22	-0.49	-0.43	-1.13	Upgrade
P/FCF Ratio	-	-	-	528.93	-	110.52	Upgrade
P/OCF Ratio	-	-	-	100.07	-	108.10	Upgrade
EV/Sales Ratio	8.61	8.59	6.26	7.65	5.86	9.25	Upgrade
EV/FCF Ratio	-	-	-	1245.07	-	174.81	Upgrade
Debt / Equity Ratio	-0.70	-0.70	-0.72	-0.72	-0.71	-0.71	Upgrade
Debt / FCF Ratio	-	-	-	782.00	-	69.28	Upgrade
Asset Turnover	1.41	1.41	1.13	1.12	1.13	0.87	Upgrade
Inventory Turnover	5.14	5.14	9.79	1.22	1.63	2.21	Upgrade
Quick Ratio	0.04	0.04	0.08	0.08	0.10	0.13	Upgrade
Current Ratio	0.06	0.06	0.10	0.10	0.12	0.15	Upgrade
Return on Assets (ROA)	-35.74%	-35.74%	-11.45%	-15.28%	-9.01%	-15.43%	Upgrade
Earnings Yield	-25.43%	-25.43%	-28.79%	-18.66%	-10.70%	-7.71%	Upgrade
FCF Yield	-	-4.56%	-2.21%	0.19%	-0.48%	0.91%	Upgrade
Buyback Yield / Dilution	-	-	-11.39%	-	-	-5.55%	Upgrade

Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.